Correlation between insulin resistance and breast elasticity heterogeneity measured by shear wave elastography in premenopausal women – a pilot study by Rzymski, Pawel et al.
Correlation between insulin resistance and breast
elasticity heterogeneity measured by shear wave
elastography in premenopausal women – a pilot study
Pawel Rzymski
1, Piotr J. Wysocki
2, Witold Kycler
3, Tomasz Opala
1
Abstract
I In nt tr ro od du uc ct ti io on n: :   Recent studies have demonstrated a strong correlation between
obesity, insulin resistance, increased insulin and insulin-like growth factor lev-
els and the risk of breast cancer. Our study was aimed at exploring correlations
between glucose, insulin, insulin resistance, obesity and quantitatively esti-
mated breast elasticity in healthy women. 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   The pilot study included 37 premenopausal women aged
22-45 years who underwent B-mode sonography and real-time shear wave elas-
tography. Blood was collected for fasting insulin and glucose, and HOMA insulin
resistance index was calculated.
R Re es su ul lt ts s: :   The mean elasticity of glandular and fatty tissue measured in both
breasts was 12.5 ﾱ3.5 kPa and 10.9 ﾱ3.7 kPa respectively. Insulin levels did not
correlate with glandular tissue elasticity (Rs = –0.23, p = 0.15), but nearly cor-
related with fat tissue elasticity (Rs = –0.30, p = 0.06), in outer quadrants sig-
nificantly (Rs = –0.38, p = 0.02). Interestingly, a strong correlation of insulin and
insulin resistance with elasticity heterogeneity was found in fatty tissue 
(Rs = –0.59, p < 0.001 and Rs = –0.60, p < 0.001 respectively). The heterogeneity
of fatty tissue but not glandular elasticity also correlated with body mass index.
C Co on nc cl lu us si io on ns s: :   Insulin levels and insulin resistance correlate with breast fat tis-
sue heterogeneity, but their role in breast pathology remains unclear.
K Ke ey y   w wo or rd ds s: :   breast elastography, insulin, glucose, insulin resistance, obesity.
Introduction
Recent studies have demonstrated a strong correlation between obe-
sity, insulin resistance, increased insulin and insulin-like growth factor lev-
els and the risk of breast cancer. Beside its metabolism-regulating prop-
erties on a whole organism level, insulin exerts mitogenic effects in vitro
and has also been shown to inhibit apoptosis in various breast cancer cell
lines [1]. It has been generally accepted that such metabolic disorders as
hyperglycaemia and chronic hyperinsulinaemia may be important for devel-
opment of breast cancer. Additionally, another metabolic condition, obe-
sity, has been demonstrated to increase breast cancer risk in post-
menopausal, but not in premenopausal women [2]. Insulin may also
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indirectly promote breast cancer development, via
upregulation and modulation of bioavailability of
IGF-1 (insulin growth factor-1) and IGF-2 (insulin
growth factor-2), especially in the tumour microen-
vironment [3]. It has been proposed that insulin and
IGF-1 act directly as paracrine and autocrine growth
factors for breast cancer cells [4] via activation of
PI3K/AKT/mTOR and RAS/RAF/MAPK signalling
pathways. Additionally, both factors may indirectly
increase the risk of breast cancer via stimulation of
proliferation of normal human mammary cells, lead-
ing to increased breast density. Mammographic
breast density has been demonstrated to be an
important risk factor for breast cancer. In women,
a simultaneous increase of female and growth hor-
mones (e.g. oestrogen, insulin, IGF-1) correlates with
the  mass  of  the  mammary  gland.  In  post-
menopausal women aromatase located within fat-
ty tissue is solely responsible for production of
oestrogens [4, 5]. Thus high activity of aromatase
in postmenopausal obese women is responsible for
high systemic oestrogen levels, which directly cor-
relate with the risk of development of hormone-
dependent breast cancer. The above described inter-
actions explain the phenomenon of increased
frequency of hormone-dependent breast cancer in
obese postmenopausal women [4]. Insulin may also
be responsible for increased oestrogen levels, since
insulin has been demonstrated to decrease the sys-
temic sex hormone binding globulin (SHBG) levels
[6]. Accordingly, insulin, obesity and insulin resist-
ance altogether represent important risk factors for
breast cancer [4, 7]. In breast cancer patients obe-
sity is a negative prognostic factor irrespectively of
the patient’s menopausal status [4]. 
As mentioned previously, mammographic breast
density represents one of the risk factors for breast
cancer. Dense breasts imply a 4-6-fold increase of
the risk of breast cancer [8]. 
Despite  the  above-mentioned  interactions
between insulin, glucose, obesity and mammo-
graphic breast density and breast cancer incidence,
to our best knowledge virtually no studies have
analysed these factors in the context of breast elas-
ticity. Breast sonoelastography is a relatively new
but rapidly evolving diagnostic modality. Our study
was aimed at exploring correlations between glu-
cose, insulin, insulin resistance, obesity and quan-
titatively estimated breast elasticity in healthy
women. Providing some insight into the relationship
between metabolic parameters and breast elastici-
ty may become useful information improving inter-
pretation of sonoelastograms in clinical practice.
Material and methods
The current study included 37 premenopausal
women aged 22-45 years who underwent B-mode
sonography in the Gynaecological and Obstetrical
University Hospital in Poznan, Poland. All patients
underwent a routine diagnostic procedure due to
menstrual disorders. Patients underwent gynaeco-
logical examination and blood samples were col-
lected on the 7th day of the menstrual cycle for esti-
mation of insulin and glucose levels. The day was
chosen  because  of  ultrasound  examination.
Because of menstrual disorders in all patients, fol-
licle stimulating hormone (FSH), lutropin (LH),
oestradiol and prolactin levels were determined.
Based on glucose and insulin levels, the insulin
resistance  was  calculated  according  to  the 
HOMA (Homeostatic Model Assessment) formula:
HOMAIR = insulin (mU/dl) ￗ glucose (mg/dl)/40.5. 
The study was performed between November
2009 and June 2010. All subjects filled a standard
questionnaire with general medical, obstetrical and
breast history. Patients underwent B-mode breast
sonography (Aixplorer Ultrasound System, Super-
Sonic Imagine SA, France), which revealed no abnor-
malities, and were classified as BIRADS (Breast
Imaging Reporting and Data System) 1. The ultra-
sound examination as well as sonoelastography
were performed by a highly experienced gynaecol-
ogist (P .R.). Equipment used in this study makes pos-
sible normal ultrasound scanning with a linear
probe (at 15 MHz) and real-time sonoelastography.
The methodology was based on the generation of
a remote radiation force by focused ultrasonic
beams. Each pushing beam generates a remote
vibration that results in transient shear wave prop-
agation. Several pushing beams transmitted at dif-
ferent depths result in a quasi-plane shear wave
front which propagates through the whole imaging
region of interest (ROI) [1, 2]. Following the stan-
dard B-mode ultrasound scanning, the second part
of the examination was performed in the scheme
designed for this study. The left and right breast
were divided into 8 quadrants and 8 scans of nor-
mal breast tissue from both breasts were acquired
with elastography mode.
During acquisition a single scan of the ROI was
set to include subcutaneous fat at the top and the
margin of the pectoral muscle at the bottom. The
best greyscale scan was used to identify glandular
and fat tissue. All elastography scans included
measurements with 2 mm to 3 mm diameter Q-box
(area of elasticity measurement in kPa) in glandu-
lar and fat tissue. The chosen area was typical and
representative for glandular and fatty tissue in
greyscale ultrasound and Q-box diameter depend-
ed on the tissue diameters. Parameters included
mean elasticity in Q-box, minimal and maximal
elasticity in Q-box, and standard deviation (SD), as
supplied by ultrasound device software. Addition-
ally we calculated the heterogeneity of the sonoe-
lasticity map in Q-Box, which represents a colour-
coded  map  of  elasticity.  For  this  purpose  weArch Med Sci 6, December / 2011 1019
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calculated the minimum to maximum range of this
map (heterogeneity minimum-maximum) and divid-
ed it by the minimal elasticity value (heterogene-
ity as percent of minimal value) and mean value
(heterogeneity as percent of mean value). From all
37 patients, 296 elastography scans were achieved
from 8 quadrants. For analysis we calculated glan-
dular to fatty tissue ratio and we also grouped
breast quadrants into inner (scans 3, 4, 5 and 6)
and outer (scans 1, 2, 7 and 8). 
All data were stored in an MS Excel spreadsheet
(Microsoft Corp, USA) and analysed with Sigma  -
Stat 3.1 (Jandel Corp, USA). The normal distribution
was confirmed by Kolmogorov-Smirnov test. The
correlation between parameters were checked by
Spearman’s test. Values p less than 0.05 were con-
sidered significant. We used two-tailed tests to
examine  the  significance  in  both  previously
unknown directions. The study was approved by
the local bioethics committee and patients gave
their written consent. 
Results
A An na al ly ys si is s   o of f   b br re ea as st t   t ti is ss su ue e   e el la as st ti ic ci it ty y
The mean elasticity of glandular and fatty tissue
measured in both breasts was 12.5 ﾱ3.5 kPa and
10.9 ﾱ3.7 kPa respectively. Glandular tissue elastic-
ity in inner and outer quadrants was 14.6 ﾱ4.8 kPa
and 10.3 ﾱ3.1 kPa respectively. Analogically, fatty tis-
sue elasticity in inner and outer quadrants was 
12.7 ﾱ5.3 kPa and 9.0 ﾱ3.2 kPa respectively. 
C Co or rr re el la at ti io on n   o of f   b br re ea as st t   e el la as st ti ic ci it ty y   w wi it th h   m me et ta ab bo ol li ic c
p pa ar ra am me et te er rs s
Insulin levels did not correlate with glandular tis-
sue elasticity (Rs = –0.23, p = 0.15), but nearly cor-
related  with  fat  tissue  elasticity  (Rs  =  –0.30, 
p = 0.06). This tendency referring to fat tissue was
different in inner and outer quadrants, where cor-
relations were insignificant (Rs = –0.24, p = 0.16)
and significant (Rs = –0.38, p = 0.02) respectively.
The HOMA index did not correlate with glandular
tissue elasticity and reached borderline significance
in fatty tissue (Rs = –0.31, p = 0.055). 
A An na al ly ys si is s   o of f   h he et te er ro og ge en ne ei it ty y   o of f   e el la as st ti ic ci it ty y
As the next step we analysed heterogeneity of
the elasticity map in Q-box. The results of the cor-
relations with insulin, glucose, and HOMA index are
presented in Table I. Interestingly, a strong correla-
tion of insulin and insulin resistance was found 
in fatty tissue. The correlation is presented in Fig-
E El la as st to og gr ra ap ph hi ic c   p pa ar ra am me et te er r I In ns su ul li in n   [ [m mU U/ /m ml l] ] G Gl lu uc co os se e   [ [m mg g/ /d dl l] ] I In ns su ul li in n   r re es si is st ta an nc ce e   
( (H HO OM MA A   I IR R) )* *
G Gl la an nd du ul la ar r   t ti is ss su ue e
Heterogeneity (min-max) [kPa] Rs = –0.22  Rs = –0.10 Rs = –0.22
p = 0.18 p = 0.54 p = 0.19
Heterogeneity of inner quadrants (min-max) [kPa] Rs = –0.15 Rs = –0.07 Rs = –0.15
p = 0.35 p = 0.67 p = 0.37
Heterogeneity of outer quadrants (min-max) [kPa] Rs = –0.10 Rs = –0.01 Rs = –0.09
p = 0.55 p = 0.93 p = 0.56
Heterogeneity (% of mean) Rs = 0.08 Rs = –0.05 Rs = 0.08
p = 0.59 p = 0.76 p = 0.61
Heterogeneity (% of minimum) Rs = 0.08 Rs = –0.07 Rs = 0.07
p = 0.61 p = 0.65 p = 0.63
F Fa at t   t ti is ss su ue e
Heterogeneity (min-max) [kPa] Rs = –0.59 Rs = –0.256 Rs = –0.60
p < 0.001 p = 0.125 p < 0.001
Heterogeneity of inner quadrants (min-max) [kPa] Rs = –0.46 Rs = –0.165  Rs = –0.45
p = 0.004 p = 328 p = 0.005
Heterogeneity of outer quadrants (min-max) [kPa] Rs = –0.48 Rs = –0.237 Rs = –0.50
p = 0.002 p = 0.157 p = 0.001
Heterogeneity (% of mean) Rs = –0.38 Rs = –0.17 Rs = –0.383
p = 0.022 p = 0.314 p = 0.019
Heterogeneity (% of minimum) Rs = –0.39 Rs = –0.17 Rs = –0.41
p = 0.016 p = 0.29 p = 0.013
*HOMA IR = insulin [mU/dl] x glucose [mg/dl]/40.5
T Ta ab bl le e   I I. . Correlations of breast elastographic parameters with insulin, glucose and insulin resistance1020 Arch Med Sci 6, December / 2011
ures 1 and 2. Correlations of elasticity heterogene-
ity and other breast cancer risk factors such as body
mass index (BMI), lack of lactation or deliveries are
presented in Table II.
Discussion
Mammographic breast density is one of the
strongest risk factors for breast cancer [8]. It reflects
variations in the tissue composition of the breast,
and is associated positively with collagen and epithe-
lial and non-epithelial cells, and negatively with fat.
Several cross-sectional studies have been carried out
in order to evaluate the influence of various factors
on this condition. Data from these studies demon-
strate that the extent of mammographic breast den-
sity may be associated with increased levels of 
IGF-1 and decreased levels of IGF binding protein-3
(IGFBP-3) in premenopausal women [9, 10]. 
The influence of insulin and insulin resistance
on mammographic breast density is controversial.
Wolin et al. did not find any correlation between
insulin levels, HOMA index and breast mammo-
graphic density, and demonstrated only a modest
correlation between sedentary time (which usual-
E El la as st to og gr ra ap ph hi ic c   p pa ar ra am me et te er r B BM MI I A Ag ge e   o of f   f fi ir rs st t   d de el li iv ve er ry y    L La ac ct ta at ti io on n   
[ [k kg g/ /m m2 2] ] [ [y ye ea ar rs s] ] [ [m mo on nt th hs s] ]
G Gl la an nd du ul la ar r   t ti is ss su ue e
Heterogeneity (min-max) [kPa] Rs = –0.38 Rs = –0.19 Rs = –0.08
p = 0.017 p = 0.58 p = 0.62
Heterogeneity of inner quadrants (min-max) [kPa] Rs = –0.22 Rs = –0.01 Rs = –0.13
p = 0.17 p = 0.94 p = 0.43
Heterogeneity of outer quadrants (min-max) [kPa] Rs = –0.20 Rs = –0.42 Rs = 0.03
p = 0.23 p = 0.22 p = 0.81
Heterogeneity (% of mean) Rs = –0.05 Rs = –0.02 Rs = 0.13
p = 0.76 p = 0.91 p = 0.41
Heterogeneity (% of minimum) Rs = –0.05 Rs = –0.02 Rs = –0.14
p = 0.76 p = 0.91 p = 0.39
F Fa at t   t ti is ss su ue e
Heterogeneity (min-max) [kPa] Rs = –0.59 Rs = –0.39 Rs = –0.08
p < 0.001 p = 0.26 p = 0.59
Heterogeneity of inner quadrants (min-max) [kPa] Rs = –0.45 Rs = –0.29 Rs = –0.08
p = 0.005 p = 0.40 p = 0.61
Heterogeneity of outer quadrants (min-max) [kPa] Rs = –0.47 Rs = –0.14 Rs = –0.07
p = 0.003 p = 0.67 p = 0.66
Heterogeneity (% of mean) Rs = –0.24 Rs = 0.10 Rs = –0.09
p = 0.14 p = 0.77 p = 0.61
Heterogeneity (% of minimum) Rs = –0.26 Rs = 0.17 Rs = –0.05
p = 0.11 p = 0.61 p = 0.74
T Ta ab bl le e   I II I. .   Correlations of breast elastographic parameters with other breast cancer risk factors
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ly correlates with obesity/insulin resistance and
some poor dietary practices) and breast density [11].
In that study, breast density was increased by
0.25% for every 100 min more spent sitting. Diorio
et al. demonstrated that elevated levels of C-pep-
tide (a marker of insulin secretion) as a single fac-
tor correlated with decreased breast density; how-
ever, the significance was lost when adjusted for
adiposity [12]. These observations were confirmed
in other studies, which generally showed that just
elevated insulin or C-peptide levels do not increase
the risk of breast cancer [13, 14]. However, Malin et
al. found a strong correlation between insulin resist-
ance and breast cancer risk in a dose-dependent
manner. This relation was constant even when
women were analysed separately according to their
menopausal status [7]. This observation has been
confirmed in a recent prospective study which
demonstrated that insulin resistance and obesity
significantly influence risk of breast cancer devel-
opment and progression [15]. 
Metabolic syndrome is a condition involving
beside hypertension various metabolic disorders
such as abdominal obesity, high blood glucose lev-
els, impaired glucose tolerance and dyslipidaemia.
Kabat et al. demonstrated a positive association
between metabolic syndrome and breast cancer
[16]. Population studies have shown that metformin
is associated with a significant reduction of breast
cancer risk [17].
Metabolic syndrome and mammographic breast
density seem to represent independent risk factors
for breast cancer. A recent study has demonstrat-
ed an inverse correlation between metabolic syn-
drome and breast density in pre- and early peri-
menopausal women [18]. Adiposity and increased
glucose levels were significantly inversely correlat-
ed with breast density. This observation confirms
the role of obesity as a factor associated with
decreased risk of breast cancer incidence in pre-
menopausal women. Actually, only in the context
of the above observation can we discuss the results
of our own study, since in the literature there are
virtually no data on the correlation of mammo-
graphic breast density with sonographic breast elas-
ticity.
In our study we have analysed the correlation of
breast elasticity in premenopausal women with var-
ious metabolic parameters. We have demonstrat-
ed an inverse correlation between insulin levels,
HOMA  index  and  breast  heterogeneity,  which
meant  that  breast  fatty  tissue  homogeneity
increased with increasing insulin resistance. No
such correlation was observed with respect to glan-
dular tissue. 
As Conroy et al. have demonstrated, mammo-
graphic breast density was decreased in otherwise
healthy premenopausal women presenting with
obesity or increased fasting glucose levels [18]. In
our study, in a similar population the above-men-
tioned metabolic parameters significantly correlat-
ed with increased homogeneity of breast fatty tis-
sue. As mentioned above, increasing amounts of
fatty tissue result in decreased mammographic
breast density. Accordingly, one may assume that
increased homogeneity of breast fatty tissue may
represent a surrogate indicator of decreased mam-
mographic breast density.
Samani et al. [19] discussed the heterogeneity
of breast tissue in the context of breast tumours.
Heterogeneity in Young’s modulus variability was
observed both in visual and pathological assess-
ment using a microscope in tumours. They often
consist of piecewise homogeneous abnormal tis-
sues with pockets of normal tissues randomly dis-
tributed. This potentially could represent increased
elasticity heterogeneity of tumours and other tis-
sue measures in sonoelastography [19]. There is
only one clinical study marginally dealing with
breast elasticity heterogeneity measured by shear
wave technique. The only observation was that low-
er SD values (as in our study: minimum-maximum
heterogeneity and derivative parameters) were typ-
ical for normal tissue and higher for cancers [20].
There are several questions related to the impor-
tance of the phenomenon observed in our study. It
is possible that evaluation of breast elasticity in the
context of insulin resistance may provide some
information on the risk of development and even-
tually  progression  of  breast  cancer  in  pre-
menopausal women. It might also represent a pre-
dictive factor in breast cancer management and an
argument for metformin therapy [6]. Chala et al.
found  that  in  postmenopausal  breast  cancer
patients the response to chemotherapy correlated
with decreased insulin levels [5].   
Furthermore, the pilot nature of our study result-
ed in the first, to our knowledge, presentation of
data linking quantitative breast elasticity measured
by share wave sonography and obesity, insulin and
insulin resistance as selected breast cancer risk fac-
tors. In order to profoundly explore such a relatively
new technique as shear wave sonography, one
must not only estimate its diagnostic power but
also evaluate sonoelastographic findings in the con-
text of physiology and pathology of the breast. The
B-mode ultrasound was also evaluated in relation
to these parameters and plays a huge role in clini-
cal practice nowadays. 
Unfortunately, in our study we could not com-
pare standard mammography with sonoelastogra-
phy because of the relatively young age and lack of
indications for mammography in our patients. In
Poland, screening mammography in the standard-
risk population is only recommended for women
aged 50 years and above. However, such a study1022 Arch Med Sci 6, December / 2011
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directly comparing mammography and sonoelas-
tography in patients at high risk of breast cancer
(e.g. in BRCA1, breast cancer type 1 susceptibility
protein mutation carriers) is warranted. 
In conclusion, insulin levels and insulin resist-
ance correlate with breast fat tissue heterogeneity,
but their role in breast pathology remains unclear.
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